174 related articles for article (PubMed ID: 12080360)
41. Hepatic microcirculation in fatty liver disease.
Farrell GC; Teoh NC; McCuskey RS
Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
[TBL] [Abstract][Full Text] [Related]
42. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
43. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
[TBL] [Abstract][Full Text] [Related]
44. Adult onset of acute myeloid leukaemia (M6) in patients with Shwachman-Diamond syndrome.
Dokal I; Rule S; Chen F; Potter M; Goldman J
Br J Haematol; 1997 Oct; 99(1):171-3. PubMed ID: 9359520
[TBL] [Abstract][Full Text] [Related]
45. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.
Depil S; Deconinck E; Milpied N; Sutton L; Witz F; Jouet JP; Damaj G; Yakoub-Agha I;
Bone Marrow Transplant; 2004 Mar; 33(5):531-4. PubMed ID: 14716345
[TBL] [Abstract][Full Text] [Related]
46. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
[TBL] [Abstract][Full Text] [Related]
47. [Hepatic encephalopathy following a Whipple operation].
van Galen KP; Stam F; van Oijen AH
Ned Tijdschr Geneeskd; 2009; 153():A463. PubMed ID: 19857276
[TBL] [Abstract][Full Text] [Related]
48. Allogeneic bone marrow transplantation (BMT) in a patient with myelodysplastic syndrome (MDS) infected by hepatitis B virus (HBV) precore mutant: favorable outcome with slow tapering of immunosuppressive agents.
Kikuchi A; Kagimoto S; Kishimoto H; Yamamoto K; Hanada R
Leukemia; 2002 Nov; 16(11):2333-5. PubMed ID: 12399982
[No Abstract] [Full Text] [Related]
49. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
[TBL] [Abstract][Full Text] [Related]
50. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
Keshishian A; Zahriya K; Willes EB
Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
[TBL] [Abstract][Full Text] [Related]
51. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Miele L; Forgione A; Gasbarrini G; Grieco A
Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
[TBL] [Abstract][Full Text] [Related]
52. Acquired aplastic anaemia in seven children with severe hepatitis with or without liver failure.
Honkaniemi E; Gustafsson B; Fischler B; Nemeth A; Frost BM; Papadogiannakis N; Winiarski J
Acta Paediatr; 2007 Nov; 96(11):1660-4. PubMed ID: 17888058
[TBL] [Abstract][Full Text] [Related]
53. MRI findings in Shwachman diamond syndrome.
Ruggiero A; Molinari F; Coccia P; Attinà G; Maurizi P; Riccardi R; Bonomo L
Pediatr Blood Cancer; 2008 Feb; 50(2):352-4. PubMed ID: 17183583
[TBL] [Abstract][Full Text] [Related]
54. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
55. Molecular diagnosis of Shwachman-Diamond syndrome in a child with incomplete clinical disease phenotype.
Linden T; Ehlert K; Niemeyer CM; Fleischhack G; Jürgens H; Rossig C
Pediatr Blood Cancer; 2010 Jul; 55(1):177-9. PubMed ID: 20486183
[TBL] [Abstract][Full Text] [Related]
56. Dietary habits and nutrient intake in non-alcoholic steatohepatitis.
Toshimitsu K; Matsuura B; Ohkubo I; Niiya T; Furukawa S; Hiasa Y; Kawamura M; Ebihara K; Onji M
Nutrition; 2007 Jan; 23(1):46-52. PubMed ID: 17140767
[TBL] [Abstract][Full Text] [Related]
57. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis.
Dixon JB
Clin Liver Dis; 2007 Feb; 11(1):141-54, ix-x. PubMed ID: 17544976
[TBL] [Abstract][Full Text] [Related]
58. [Non-alcoholic steatohepatitis].
Alvarez-Martínez H; Pérez-Campos E
Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
[TBL] [Abstract][Full Text] [Related]
59. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
60. [Improvement of diabetes insipidus after allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome].
Sato N; Takayama N; Kizaki M; Ikeda Y; Okamoto S
Rinsho Ketsueki; 2003 May; 44(5):318-22. PubMed ID: 12822406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
